Electrophysiological and biochemical evaluations of neuropathy risk in oral levodopa versus levodopa/carbidopa intestinal gel treatment

Ngā tūemi rite

• Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
  mā: Mihaela Adriana Simu, me ētahi atu.
  I whakaputaina: (2021-11-01)
• A case of Frégoli syndrome following 24-hour levodopa-carbidopa intestinal gel infusion in a patient with Parkinson’s disease undergoing STN-DBS
  mā: Shunsuke Ogata, me ētahi atu.
  I whakaputaina: (2025-01-01)
• Efficacy, safety and patient’s quality of life of long-term treatment with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease in Romania: Results from GLORIA observational study
  mā: Jozsef Szasz, me ētahi atu.
  I whakaputaina: (2020-03-01)
• Electrophysiological and biochemical evaluations of neuropathy risk in oral levodopa versus levodopa/carbidopa intestinal gel treatment
  mā: Miray Erdem, me ētahi atu.
  I whakaputaina: (2025-12-01)
• Complications associated with intestinal infusion therapies in patients with Parkinson’s disease: a single-center retrospective study and 15-year experience
  mā: Igor Straka, me ētahi atu.
  I whakaputaina: (2025-05-01)